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Pelvic floor rehabilitation (PFR) is an important and recommended strategy for
the treatment of many uro-gynaecological disorders including overactive bladder
(OAB), urinary incontinence (UI), chronic pelvic pain (CPP) and pelvic organ
prolapse (POP). The recognised pioneer of PFR is the American gynaecologist
Arnold Kegel who, over 60 years ago, proposed pelvic floor muscles exercises to
prevent and/or treat female UI. Kegel’s techniques were also successfully used
by other authors, but until the first International Consultation on Incontinence
(ICI) there was no scientific consensus regarding the efficacy of PFR (Monaco,
1998).
PFR consists of biofeedback (BFB), functional electrical stimulation (FES),
pelvic floor muscle training (PFMT), endovaginal or vaginal cones (VC), and
behavioural approaches. BFB allows the subject to modify the unconscious
physiological events, while FES is aimed to inhibit OAB, and improve pelvic
“awareness”, in association with pelvic floor muscles activity. PFMT plays an
extremely important role in the conservative treatment of OAB, UI and CPP, but
in the near future it should also be proposed as an actual secondary and primary
prevention of pelvic floor dysfunction. Many Authors use the rehabilitation tech-
niques according to heterogeneous protocols: the best results are obtained when
protocols requiring intensive and/or supervised PFMT are followed.
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Urodynamics is a key tool for assessment of urinary disorders in many neuro-
logical disorders. Urodynamics assess the function and dysfunction of the lower
urinary tract, trying to reproduce the patient’s complaints and provide a patho-
physiological explanation to guide therapeutics. But for each of the different
etiologies, specific questions are addressed regarding the value of urodynamic
for diagnostic, prognostic, evaluation of treatment efficacy, and follow-up.
Urodynamic in SCI is of particular importance regarding the risk for upper uri-
nary tract impairment and morbidity and mortality related to urinary disorders.
Each arm of treatment in this population requires specific evaluation and uro-
dynamic goals. Urodynamic in MS is a subject of debate in the literature and
scientific society guidelines. The place of urodynamic in this pathology will
be discussed. Urodynamic in Parkinson disease help the clinician to make the
diagnostic of Parkinson disease or multiple system atrophy. Because of the epi-
demiology, age and gender, the question of association with prolapse and benign
prostate hypertrophy is a frequent.
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Objectives.– To assess efficacy and complications of the neurogenic stress uri-
nary incontinence by adjustable continence therapy.
Patients and method.– Retrospective multicentric study with all neurologic
patients having had an adjustable continence therapy in different French uni-
versity hospitals.
Results.– From 2001 to 2013, 102 patients have been implanted. Mean ± SD
at implantation was 48.4 ± 16.5 years. The mean follow-up was 2.7 ± 2.3
years. The mean urethral closure-pressure was 33.2 ± 18.7 cm H20. The mean
maximum detrusor storage pressure was 28.5 ± 18.1 cm H20. Among patients,
3.9% were dry, 37.3% were improved 50% or greater of whom 11.8% of
patients with 90% or greater improvement, 39.2% were improved less than
50% of whom 5.9% with treatment failure. Complications were found in 74
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